Fiona Stewart

Fiona Stewart

Auto-generated profile, based on publicly available information

Fiona Stewart

Health Services Research Unit, University of Aberdeen, Aberdeen, UK

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Health Technology Assessment
Verified
Journal Article
Closed access
AAAlison Avenell
Alison Avenell
CRClare Robertson
Clare Robertson
ZSZoë Skea
Zoë Skea
EJElisabet Jacobsen
Elisabet Jacobsen
DBDwayne Boyers
Dwayne Boyers
MBMarijn De Bruin
Marijn De Bruin
Background: Adults with severe obesity [body mass index (BMI) of ≥ 35 kg/m2] have an increased risk of comorbidities and psychological, social and economic consequences.Objectives: Systematically review bariatric surgery, weight-management programmes (WMPs) and orlistat pharmacotherapy for adults with severe obesity, and evaluate the feasibility, acceptability, clinical effectiveness and cost-effectiveness of treatment.Data sources: Electronic databases including MEDLINE, EMBASE, PsycINFO, the Cochrane Central Register of Controlled Trials and the NHS Economic Evaluation Database were searched (last searched in May 2017).Review methods: Four systematic reviews evaluated clinical effectiveness, cost-effectiveness and qualitative evidence for adults with a BMI of ≥ 35 kg/m2. Data from meta-analyses populated a microsimulation model predicting costs, outcomes and cost-effectiveness of Roux-en-Y gastric bypass (RYGB) surgery and the most effective lifestyle WMPs over a 30-year time horizon from a NHS perspective, compared with current UK population obesity trends. Interventions were cost-effective if the additional cost of achieving a quality-adjusted life-year is < £20,000–30,000.Results: A total of 131 randomised controlled trials (RCTs), 26 UK studies, 33 qualitative studies and 46 cost-effectiveness studies were included. From RCTs, RYGB produced the greatest long-term weight change [–20.23 kg, 95% confidence interval (CI) –23.75 to –16.71 kg, at 60 months]. WMPs with very low-calorie diets (VLCDs) produced the greatest weight loss at 12 months compared with no WMPs. Adding a VLCD to a WMP gave an additional mean weight change of –4.41 kg (95% CI –5.93 to –2.88 kg) at 12 months. The intensive Look AHEAD WMP produced mean long-term weight loss of 6% in people with type 2 diabetes mellitus (at a median of 9.6 years). The microsimulation model found that WMPs were generally cost-effective compared with population obesity trends. Long-term WMP weight regain was very uncertain, apart from Look AHEAD. The addition of a VLCD to a WMP was not cost-effective compared with a WMP alone. RYGB was cost-effective compared with no surgery and WMPs, but the model did not replicate long-term cost savings found in previous studies. Qualitative data suggested that participants could be attracted to take part in WMPs through endorsement by their health-care provider or through perceiving innovative activities, with WMPs being delivered to groups. Features improving long-term weight loss included having group support, additional behavioural support, a physical activity programme to attend, a prescribed calorie diet or a calorie deficit.Limitations: Reviewed studies often lacked generalisability to UK settings in terms of participants and resources for implementation, and usually lacked long-term follow-up (particularly for complications for surgery), leading to unrealistic weight regain assumptions. The views of potential and actual users of services were rarely reported to contribute to service design. This study may have failed to identify unpublished UK evaluations. Dual, blinded numerical data extraction was not undertaken.Conclusions: Roux-en-Y gastric bypass was costly to deliver, but it was the most cost-effective intervention. Adding a VLCD to a WMP was not cost-effective compared with a WMP alone. Most WMPs were cost-effective compared with current population obesity trends.Future work: Improved reporting of WMPs is needed to allow replication, translation and further research. Qualitative research is needed with adults who are potential users of, or who fail to engage with or drop out from, WMPs. RCTs and economic evaluations in UK settings (e.g. Tier 3, commercial programmes or primary care) should evaluate VLCDs with long-term follow-up (≥ 5 years). Decision models should incorporate relevant costs, disease states and evidence-based weight regain assumptions.Study registration: This study is registered as PROSPERO CRD42016040190.Funding: The National Institute for Health Research Health Technology Assessment programme. The Health Services Research Unit and Health Economics Research Unit are core funded by the Chief Scientist Office of the Scottish Government Health and Social Care Directorate.

24 September 2024 in Future Oncology
Verified
Journal Article
Open access
AFAndrea Ferreira-Gonzalez
Andrea Ferreira-Gonzalez
GKGilbert Ko
Gilbert Ko
NFNicole Fusco
Nicole Fusco
FSFiona Stewart
Fiona Stewart
KKKristin Kistler
Kristin Kistler
SBSvetlana Babajanyan
Svetlana Babajanyan
Aim: Next-generation sequencing (NGS) of solid tumors can inform treatment decisions; however, uptake remains low. This objective of this systematic review was to identify barriers to and facilitators of NGS in US oncology settings.

25 April 2024 in Journal of Medical Economics
Verified
Journal Article
Open access
FSFiona Stewart
Fiona Stewart
KKKristin Kistler
Kristin Kistler
YDYuxian Du
Yuxian Du
RSRakesh R. Singh
Rakesh R. Singh
BDBonnie B. Dean
Bonnie B. Dean
SKSheldon X. Kong
Sheldon X. Kong
IntroductionChronic kidney disease (CKD) affects an estimated 35.5 million Americans [1]. The number of individuals with end-stage renal disease (ESRD) reached 807,920 in 2020 [2], while the preval...

1 February 1996 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
WDW. Dickey
W. Dickey
FSF. Stewart
F. Stewart
JNJ. Nelson
J. Nelson
GMG. McBreen
G. McBreen
SMS. A. McMillan
S. A. McMillan
KPK. G. Porter
K. G. Porter

23 November 2012 in The Lancet
Verified
Journal Article
Closed access
PDF file
PHPat Hoddinott
Pat Hoddinott
JHJenni Hislop
Jenni Hislop
HMHeather Morgan
Heather Morgan
FSFiona Stewart
Fiona Stewart
SFShelley Farrar
Shelley Farrar
GTGill Thomson
Gill Thomson

8 July 2026 in SLEEP Advances
Verified
Journal Article
Open access
SGSomraj Ghosh
Somraj Ghosh
SCStephen Crawford
Stephen Crawford
SBSarah L Bermingham
Sarah L Bermingham
MZMiriam L Zichlin
Miriam L Zichlin
FSFiona Stewart
Fiona Stewart
KKKristin Kistler
Kristin Kistler
The symptoms experienced by people with narcolepsy and idiopathic hypersomnia (IH) have profound effects on individuals’ lives, affecting daily functioning, relationships and mental health, and can impair performance at work or school. Although numerous studies have evaluated the impact of narcolepsy and IH on work-related outcomes, the evidence base is highly fragmented and difficult to meaningfully summarize. We conducted a systematic literature review of published evidence to better understand the impact of these disorders on employment, work productivity, work satisfaction, and related outcomes. We identified 54 publications representing 51 unique studies that met the study inclusion criteria and were included in the review. Although most people with narcolepsy or IH were employed, fewer were in paid work than control populations, and absenteeism and presenteeism were high. Having narcolepsy and IH resulted in lower wages and missed work time, leading to unfavorable impacts on career progression, promotion, job satisfaction, and income. The most frequently reported work-related problems were sleepiness at work, reduced performance, work accidents, and lateness. More severe excessive daytime sleepiness was associated with greater work impairment. Narcolepsy-specific medications that improved excessive daytime sleepiness were reported to improve work productivity in clinical trials; however, many people are left with substantial residual impairment despite treatment. These findings indicate that narcolepsy and IH impose a substantial burden on work functioning and employment, and there is a need for more research to inform interventions and policies aimed at mitigating the impact of these debilitating conditions on individuals’ professional lives.